BIO-Europe® 2016: Opportunities For unpartnered assets

December 6, 2016
Steven Muntner, vice president of deals at Informa Pharma Intelligence, discusses key takeaways from a recent report looking at pharma partnering and deal trends. On the sidelines of the 2016 BIO-Europe partnering meeting, he also highlights the biggest opportunities for unpartnered assets and recent changes in the partnering landscape.
Previous Video
BIO-Europe® 2016: InflaRX CEO highlights pipeline goals
BIO-Europe® 2016: InflaRX CEO highlights pipeline goals

Niels Riedemann, founder and CEO of InflaRX, speaks to Lucie Ellis, senior writer at Scrip, about the compa...

Next Video
BIO-Europe® 2016: AdAlta CEO on shark antibody technology
BIO-Europe® 2016: AdAlta CEO on shark antibody technology

AdAlta is developing a novel technology platform that engineers the key stability features of the antigen b...